Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2023 | 0 |
Search Results
2
results
Results by year
Page 1
Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
Int J Pharm. 2020 Apr 30;580:119237. doi: 10.1016/j.ijpharm.2020.119237. Epub 2020 Mar 19.
Int J Pharm. 2020.
PMID: 32201251
This study describes the development of glycol chitosan nanoparticles, hydrophobically modified with 4-nitrobenzyl chloroformate and folic acid (FA), that can specifically release drugs under hypoxic conditions. ...
This study describes the development of glycol chitosan nanoparticles, hydrophobically modified with 4-nitrobenzyl chlorofo …
Nanocarriers responsive to a hypoxia gradient facilitate enhanced tumor penetration and improved anti-tumor efficacy.
Zhen J, Tian S, Liu Q, Zheng C, Zhang Z, Ding Y, An Y, Liu Y, Shi L.
Zhen J, et al.
Biomater Sci. 2019 Jul 1;7(7):2986-2995. doi: 10.1039/c9bm00461k. Epub 2019 May 20.
Biomater Sci. 2019.
PMID: 31106796
The nanocarrier was composed of a poly(caprolactone) core and a mixed shell of poly(ethylene glycol) (PEG) and 4-nitrobenzyl chloroformate (NBCF)-modified polylysine (PLL). During the blood circulation, the NBCF-modified PLL was shielded by the PEG, which gav …
The nanocarrier was composed of a poly(caprolactone) core and a mixed shell of poly(ethylene glycol) (PEG) and 4-nitrobenzyl …
Item in Clipboard
Cite
Cite